A review on the methods and applications of spray drying technology

Pharmaceutical Sciences

Volumn 18, Issue 2, 2012, Pages 119-132

  Adibkia, K ^a,b   Barzegar Jalali, Mohammad ^b   Javadzadeh, Y ^a   Maheri Esfanjani, H ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Applications; Review; Spray drying

Indexed keywords

DRUG;

ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; GRANULATION TISSUE; LIQUID; MICROENCAPSULATION; PARTICLE SIZE; POWDER; SPRAY DRYING;

EID: 84872550833     PISSN: 1735403X     EISSN: 23832886     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Zijlstra G. S., Rijkeboer M., JanvanD.D., SutterM., JiskootW., VandeW.Met al.Characterization of a cyclosporine solid dispersion for inhalation, AAPS. J.,2007,9:190-199.
2. Janssens S., NagelsS., ArmasH.N., D'AutryW., VanS.A., Van denM.G.Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000and PVPVA 64, that were selected based on a supersaturation screening study, Eur.J.Pharm.Biopharm.,2008,69:158-166.
3. Piao M.G., KimJ.H., Kim J.O., LyooW.S., LeeM.H.,YongC.Set al. Enhanced oral bioavailability of piroxicam in rats by hyaluronate microspheres, Drug Dev. Ind. Pharm.,2007,33:485-491.
4. Thybo P., KristensenJ., HovgaardL.Characterization and physical stability of tolfenamic acid-PVP K30 solid dispersions, Pharm. Dev. Technol.,2007,12:43- 53.
5. Aiedeh K.M., Khatib, H. A., Taha, M.O., Al-ZoubiN.Application of novel chitosan derivatives in dissolution enhancement of a poorly water soluble drug, Pharmazie.,2006,4:306-311.
6. Paradkar A., AmbikeA.A., JadhavB.K., MahadikK.R.Characterization of curcumin-PVP solid dispersion obtained by spray drying, Int. J. Pharm.,2004,271:281-286.
7. Koester L.S., MayorgaP., BassaniV.L.Carbamazepine/betaCD/HPMC solid dispersions. I. Influence of the spray-drying process and betaCD/HPMC on the drug dissolution profile, Drug Dev. Ind. Pharm.,2003,29:139-144.
8. Gohel C. M., ParikhK.R., NagoriS.A., BariyaH.S., GandhiV.A., ShroffS.Met al . Spray Drying: A Review, Pharmainfo.,2009, [online] article review available athttp://www.pharmainfo.net/reviews/spray-drying-review (10 January 2012).
9. Patel R.P., Patel M.P., SutharM.Spray drying technology: an overview, Indian Journal of Science and Technology.,2009,10: 244-247.
10. BETE Spray Dry Manual., BETE Fog Nozzle, Inc 2005 information [online] available at http://www.bete.com/pdfs/BETE-SprayDryManual.pdf (10 January 2012).
11. Parihari A.Performance Study Of Spray Dryer Using Various Salt Solutions, A thesis submited to national Institute of technology,ROURKELA for the degree of master in technology in chemical engineering.,2009.
12. APV DRYER HANDBOOK., APV Limited Company. 2006. "APV Dryer Handbook." [Online]. Available at http://www.che.utexas.edu/cache/trc/ dryer.pdf (8 September 2011).
13. Stefanescu A.E.Influence of key parameters on the morphology of ethylcellulose microcapsules prepared via room-temperature spray drying, Cellulose.,2010,17:617-626.
14. Steckel H., BrandesG.H.A novel spray-drying technique to producelow density particles for pulmonary delivery, International Journal of Pharmaceutics., 2004,278:187-195.
15. Dobry E. D., SettelM.D., Baumann M.J., Ray O J., Graham J.L., Beyerinck A.R.A Model-Based Methodology for Spray-Drying Process Development, J Pharm Innov., 2009, 4:133-142.
16. Louey D.M., Oort V.M., Hickey J.A.Aerosol Dispersion of Respirable Particles in Narrow Size Distributions Produced by Jet-Milling and Spray-Drying Techniques, Pharmaceutical Research.,2004,21:1200-1206.
17. Mizoe T., OzekiT, OkadaH.Application of a Four-fluid Nozzle Spray Drier to Prepare Inhalable Rifampicin-containing Mannitol Microparticles, AAPS PharmSciTech.,2008,9:755-761.
18. Parlati C., Colombo C., Buttini F., Young M.P., Adi H., Ammit J. Aet al. Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency, Pharmaceutical Research.,2009,26:1084-1092.
19. Dahlberg C., Millqvist-FurebyA., SchuleitM.Surface composition and contact angle relationships for differently prepared solid dispersions, Eur. J. Pharm. Biopharm.,2008,70:478-485.
20. Asada M., TakahashiH., OkamotoH., Tanino,H., DanjoK.Theophylline particle design using chitosan by the spray drying, Int. J. Pharm.,2004,270:167-174.
21. Li D. X., JangK.Y., Kang W., .BaeK., Lee, M. H., Oh Y.Ket al . Enhanced solubility and bioavailability of sibutramine base by solid dispersion system with aqueous medium, Biol. Pharm. Bull.,2010,33:279-284.
22. Takahashi H., ChenR., Okamoto H., Danjo K.Acetaminophen particle design using chitosan and a spray-drying technique, Chem. Pharm. Bull. (Tokyo).,2005,53:37-41.
23. Gupta P., Bansal A.K.Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine, Pharm. Dev. Technol.,2005,10:273-281.
24. Chauhan B., Shimpi S., Paradkar A.Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique, AAPS. PharmSciTech.,2005,6:405-412.
25. Shen S. C., Ng W. K., Chia L., Dong Y.C., Tan R.B.Stabilized amorphous state ofibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties, J. Pharm. Sci.,2010,99:1997-2007.
26. Shimpi S. L., Mahadik K R., Paradkar A.R.Study on mechanism for amorphous drug stabilization using gelucire 50/13, Chem. Pharm. Bull. (Tokyo).,2009,57:937-942.
27. Dhumal R. S., Biradar S.V., Aher S., Paradkar A.R.Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability, J. Pharm. Pharmacol.,2009,61:743-751.
28. Van E. B., Van S. M., Mols R., Houthoofd K., Martens J. A., Froyen L.et al.Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance, Eur. J. Pharm. Sci.,2009,38:270-278.
29. Park Y. J., Ryu D.S., Li D.X., Quan Q.Z, .Oh D.H., Kim J.Oet al. Physicochemical characterization of tacrolimus-loaded solid dispersion with sodium carboxylmethyl cellulose and sodium lauryl sulfate, Arch. Pharm. Res.,2009,32:893-898
30. Janssens S., Anne M., Rombaut P., Van den M.G.Spray drying from complex solvent systems broadens the applicability of Kollicoat IR as a carrier in the formulation of solid dispersions, Eur. J. Pharm. Sci.,2009,37:241-248.
31. Al-Obaidi H., Brocchini S., Buckton G.Anomalous properties of spray dried solid dispersions, J. Pharm. Sci.,2009,98:4724-4737.
32. Janssens S., Humbeeck J V., Van den M.G.Evaluation of the formulation of solid dispersions by co-spray drying itraconazole with Inutec SP1, a polymeric surfactant, in combination with PVPVA 64, Eur. J. Pharm . Biopharm.,2008,70:500- 505.
33. Chauhan B., Shimpi S., Paradkar A.Preparation and evaluation of glibenclamide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying technique, Eur. J. Pharm. Sci.,2005,26:219-230.
34. Cilurzo F., Minghetti P., Casiraghi A., Montanari L.Characterization of nifedipine solid dispersions, Int. J. Pharm.,2002,242:313-317.
35. Lee E.J., Lee S.W., Choi H. G., Kim C.K.Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres, Int. J. Pharm.,2001,218:125-131.
36. Pandya P., Gattani S., Jain P., Khirwal L., Surana S. Co-solvent Evaporation Method for Enhancement of Solubility and Dissolution Rate of Poorly Aqueous Soluble Drug Simvastatin :In vitro-In vivo Evaluation,AAPS Pharm. Sci. Tech.,2008,9: 1247-1252.
37. Chen R., Tagawa M., Hoshi N., Ogura T., Okamoto H., Danjo K.Improved dissolution of an insoluble drug using a 4-fluid nozzle spray-drying technique, Chem. Pharm. Bull. (Tokyo).,2004,52:1066-1070
38. Ambike A.A., Mahadik K. R., Paradkar A.Stability study of amorphous valdecoxib, Int. J. Pharm.,2004,282:151-162.
39. Chaubal V.M., Popescu C.Conversion of Nanosuspensions into Dry Powders by Spray Drying: A Case Study, Pharmaceutical Research.,2008,25:2302-2308
40. Takeuchi H., Nagira S., Tanimura S.,Yamamoto H., Kawashima Y.Tabletting of solid dispersion particles consisting of indomethacin and porous silica particles, Chem. Pharm. Bull. (Tokyo).,2005,53:487-491.